Scoop has an Ethical Paywall
Recall of 2 batches of GlucaGen® HypoKit
Novo Nordisk Ltd is recalling 2 batches of GlucaGen® HypoKit in New Zealand.
Auckland, New Zealand, Thursday 8th September 2016
Novo Nordisk Pharmaceuticals Limited is recalling 2 batches of GlucaGen® HypoKit in New Zealand. The GlucaGen® HypoKit is indicated for the ‘treatment of severe hypoglycaemic reactions (low blood sugar) which may occur in the management of diabetic patients receiving insulin or oral hypoglycaemic agents’.
Novo Nordisk conducted an investigation showing a small number (0.006%) of needles were detached from the pre-filled syringe supplied in certain batches of GlucaGen® HypoKit. To protect patient safety Novo Nordisk is recalling affected batches from wholesalers, pharmacies and patients in New Zealand.
The recalled GlucaGen® HypoKit batch numbers and
expiry dates are:
Batch No: FS6X537, Expiry:
31-Aug-2017
Batch No: FS6X873, Expiry:
31-Aug-2017
ends
Whanganui Regional Museum: Historic Wedding Dress Unveiled, A Piece Of Marton’s Heritage
Donovan Ryan: Local Runner Takes Out Frontrunner Christchurch Marathon
University of Auckland: Tributes Flow For Much Loved Pacific Leader Melegalenu’u Ah Sam
NZEI: Ministry Of Education Cuts Will Disproportionately Affect Pasifika
Day One Hapai te Haeata: Call To Action For Young Filmmakers Against The Backdrop Of Funding Cuts
Toyota New Zealand: Three Races For Top Three To Decide TR86 Title